Ingevity Corp (NGVT) research
Ingevity Corp- Sector
- Chemicals
- Last price
- $68.96
- As of
Ingevity Corp (NGVT): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-07-30.
As of . Source: SEC EDGAR filings for NGVT. Method and limitations.
Share the NGVT intelligence card
See NGVT live in the terminal
Track NGVT's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live NGVT terminal, freeActive signals for NGVT
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 78% of NGVT (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +308% to NGVT (2026Q2)
- mediumNEW_POSITION
TWO SIGMA INVESTMENTS, LP new position in NGVT
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 78% of NGVT (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +308% to NGVT (2026Q2)
FREE, NO ACCOUNT
Every signal on NGVT, as it fires
You are seeing 5 of 17 signals recorded on NGVT since 2026-05-26.
The five above all landed on 2026-09-06. The other 12 were recorded on 4 other days. 12 of the 17 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in NGVT (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 45688C107 · 2026Q2 | $74.1M | 0.03% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 45688C107 · 2026Q2 | $4.7M | 0.01% | , |
| Bridgewater Associates, LPCUSIP 45688C107 · 2026Q2 | $1.6M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 45688C107 · 2026Q2 | $1.2M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 45688C107 · 2026Q2 | $1.1M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 45688C107 · 2026Q2 | $441K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, NGVT
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
NGVT against its peers
NGVT's operating margin of 35.9% ranks in the 98th percentile of 20 Chemicals sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-01-31.
| Metric | NGVT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.2B USD | 2.7B USD | 23 | 23 |
| Gross margin | 39.5% | 23.0% | 98 | 20 |
| Operating margin | 35.9% | 4.8% | 98 | 20 |
| Net margin | -14.3% | 2.5% | 19 | 23 |
| Return on equity | -562.6% | 3.4% | 2 | 21 |
| P / E | n/a | 20.1x | n/a | 11 |
Peers (23): IOSP, CC, MTX, OLN, SMG, ASH, HUN, AVNT, SCL, REX, CBT, FMC, PCT, MEOH, CE, BCPC, KRO, KOP, LXU, WLKP, EMN, TROX, NEU. Left out: SVYSF (no annual filing), SYNSY (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-01-31. Every figure is one full fiscal year read from one annual filing (NGVT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more NGVT signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to NGVTand get the insider, 13F, options, and confluence read in one view.